What can we help you find?

Leading the way in organ transplantation

Filter results for:

Technical & Logistical aspects of Performing Normothermic Regional Perfusion in Controlled Donation after Circulatory Death in Europe

A working group of European experts has summarised the current technique and logistical aspects as they are implemented in their countries and / or centres. From these discussions, and supported by literature, the TJL2.0 Work Stream has created a list of recommendations and minimal requirements any NRP programme should follow.  We ask your help to…

Read more

The COVID-19 Vaccine Studies

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader…

Read more

Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer – Open for comments until 06 April

This pre-print from TLJ 2.0 WS03 on ‘Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancer’ is now open for comments on Transplant Live. Led by Umberto Maggiore, this paper will be submitted to Transplant International once feedback from our community has been collated. Login & provide your input today…

Read more

It’s time to prepare your abstract submission for #ESOTcongress

The ESOT Congress serves as a premier platform for researchers from across the globe to present their organ transplantation research, the abstract submission is open, with the following key submission deadlines: Abstract submission: 22 February 2021 Late-breaking abstract submission period: 10-25 May 2021 (preliminary research must be provided by 22 February 2021) Find out more by reading our abstract and clinical…

Read more